Navigation Links
Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014
Date:8/1/2014

JUPITER, Fla., Aug. 1, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for the second quarter ended June 30, 2014 after market close on Thursday, August 14, 2014 and will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results.

(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )

In order to participate in the live session, please use the following dial-in numbers five to ten minutes prior to start time:

Calling from the United States or Canada:  888-596-2611

Calling from other countries:  913-981-5559

Confirmation Code:  1132588

A replay of the conference call will be available on Dyadic's website (www.dyadic.com) within 24 hours after the live event.

About Dyadic

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries. Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 microorganism, which enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. The C1 platform technology can also be used to screen for the discovery of novel genes. In addition to the sale of proprietary enzyme products, Dyadic actively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the enzymes and other proteins which these technologies help produce.  Please visit Dyadic's website at www.dyadic.com.  Dyadic trades on the OTCQX tier of the OTC marketplace. Investors can find real-time quotes, market information and financial reports for Dyadic on the OTC marketplace website at www.otcmarkets.com/stock/DYAI/quote.

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks, uncertainties and other factors that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Investors are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Any forward-looking statements speak only as of the date of this press release and, except as required by law, Dyadic expressly disclaims any intent or obligation to update or revise any forward-looking statements to reflect actual results, any changes in expectations or any change in events. Factors that could cause results to differ materially include, but are not limited to: (1) general economic conditions, including the recent conditions in the global markets; (2) Dyadic's ability to retain and attract employees; (3) competitive pressures and reliance on key customers and collaborators; (4) Dyadic's research and development efforts, (5) the outcome of the current litigation by Dyadic against its former counsel and (6) other factors discussed in Dyadic's publicly available filings, including the risk factors included in Dyadic's Annual Report filed with the OTC Markets Group on March 31, 2014.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Dyadic Netherlands To Develop Enzymes For EU-Funded Research Consortium
2. Dyadic International To Announce Third Quarter 2012 Financial Results And Host Conference Call On Thursday, November 8, 2012
3. Dyadic International Reports Profitable 2012 Full Year Financial Results
4. Dyadic International Extends All Debt Maturity Dates
5. New U.S. Patent Issued To Dyadic International
6. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
8. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
9. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
10. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
11. Chindex International, Inc. to Report First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... In China , we say ... Upgrade of China,s Healthy Strategy originates. ... for Economic and Social Development of the People,s ... the state council of the People,s Republic of ... industry development plan, identifying medical devices as one of the ...
(Date:1/18/2017)... Ximbio, a non-profit online one-stop-shop for the global ... first North American headquarters in Kendall Square, Cambridge, ... ... launch in October 2014 as a business unit of UK- ... the foundation Cancer Research UK. Ximbio.com allows scientists ...
(Date:1/18/2017)... and Drug Administration CSL CureVac Daiichi ... Drug Administration FORT Fresenius Pharmaceuticals Gamma ... GlaxoWellcome Global Influenza Programme Grippol ... Targeting Systems Indian Association of Paediatrics Janssen Pharmaceuticals ... Krka Pharmaceuticals Medicago Medicare ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... Delaware farmer Rick Dickerson attended the 2017 ... of Laurel, farms about a thousand acres of soybeans, corn and wheat, and raises ... pumpkins and other vegetables for the fresh market. He also operates a roadside stand ...
(Date:1/18/2017)... and SHANGHAI, China – , ... ... Global public health organization NSF International has certified the first ... NSF/ANSI 53: Drinking Water Treatment Units – Health Effects, an ... verifies that MicroCeramics’ NanoNose Pitcher Filter System filters the water ...
(Date:1/18/2017)... ... January 18, 2017 , ... PrideStaff, a national, franchised ... Development, Paula Turner Pizarro, was recently featured on Fox Business Network's Worldwide Business ... top business leaders from across the globe, provides viewers an opportunity to find ...
(Date:1/18/2017)... ... January 18, 2017 , ... Dr. Farhan Qureshi is an esteemed dentist who ... modern dental practice has two convenient office locations in Alexandria and Arlington, Virginia. Recently, ... for the Alexandria area. This award confirms the fact that Dr. Qureshi’s patients ...
(Date:1/18/2017)... ... January 18, 2017 , ... Rollerblade®, ... Brake Technology (ABT), an innovative braking system that allows skaters of all levels ... one of the biggest concerns of beginner and intermediate skaters – learning how ...
Breaking Medicine News(10 mins):